The Incidence and Possible Predictors of Coronary Restenosis
Filatova A. Y., Romasov I. V., Potekhina A. V., Osokina A. K., Noeva E. A., Arefieva T. I., Barabanova E. A., Merkulov E. V., Samko A. N., Provatorov S. I.
Кардиология
Vol.60, Issue2, P. 10-16
Опубликовано: 2020
Тип ресурса: Статья
DOI:10.18087/cardio.2020.2.n621
Аннотация:
Objective Assess time and possible predictors of restenosis after the implantation of first- A nd second-generation coronary stents and bare metal stents (BMSs) in patients with stable coronary artery disease after elective coronary stenting. Materials and Methods From 2010 to 2014, 3,732 (2,897 males, 60 [53; 68] years old) patients with stable exertional angina of functional class I-III underwent coronary stenting. From 2014 to 2017, 1,487 (1,173 males and 314 females) patients returned. Repeat coronary angiography was performed in 699 patients. Results A total of 644 first-generation stents, 5,321 second-generation stents, and 473 BMSs were implanted. During the control coronary angiography, contrasting was repeated for 193 first-generation stents, 899 second-generation stents, and 77 BMSs. Restenosis (stenosis of 50 [%] or more in the previously stented segment) was detected in 28 (14 [%] of angiographic control) first-generation drug-eluting stents, 94 (10 [%]) second-generation drug-el
Ключевые слова:
Atherosclerosis; Coronary stenting; High-sensitivity c-reactive protein; Restenosis
C reactive protein; adult; aged; angina pectoris; area under the curve; Article; controlled study; coronary angiography; coronary artery disease; coronary stenting; female; human; major clinical study; male; restenosis; survival analysis; survival rate; drug eluting stent; incidence; middle aged; restenosis; stent; treatment outcome; Aged; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Stents; Treatment Outcome
Язык текста: Английский
ISSN: 0022-9040
Filatova A. Y. A.Yu.
Romasov I. V.
Potekhina A. V.
Osokina A. K.
Noeva E. A.
Arefieva T. I.
Barabanova E. A. Elena Aleksandrovna 1953-
Merkulov E. V.
Samko A. N.
Provatorov S. I.
Филатова А. Y. А.Ю.
Ромасов И. В.
Потехина А. В.
Осокина А. К.
Ноева Е. А.
Арефиева Т. И.
Барабанова Е. А. Елена Александровна 1953-
Меркулов Е. В.
Самко А. Н.
Проваторов С. И.
The Incidence and Possible Predictors of Coronary Restenosis
Текст визуальный непосредственный
Кардиология
Общество специалистов по сердечной недостаточности
Vol.60, Issue2 P. 10-16
2020
Статья
Atherosclerosis Coronary stenting High-sensitivity c-reactive protein Restenosis
C reactive protein adult aged angina pectoris area under the curve Article controlled study coronary angiography coronary artery disease coronary stenting female human major clinical study male restenosis survival analysis survival rate drug eluting stent incidence middle aged restenosis stent treatment outcome Aged Coronary Angiography Coronary Restenosis Drug-Eluting Stents Female Humans Incidence Male Middle Aged Stents Treatment Outcome
Objective Assess time and possible predictors of restenosis after the implantation of first- A nd second-generation coronary stents and bare metal stents (BMSs) in patients with stable coronary artery disease after elective coronary stenting. Materials and Methods From 2010 to 2014, 3,732 (2,897 males, 60 [53; 68] years old) patients with stable exertional angina of functional class I-III underwent coronary stenting. From 2014 to 2017, 1,487 (1,173 males and 314 females) patients returned. Repeat coronary angiography was performed in 699 patients. Results A total of 644 first-generation stents, 5,321 second-generation stents, and 473 BMSs were implanted. During the control coronary angiography, contrasting was repeated for 193 first-generation stents, 899 second-generation stents, and 77 BMSs. Restenosis (stenosis of 50 [%] or more in the previously stented segment) was detected in 28 (14 [%] of angiographic control) first-generation drug-eluting stents, 94 (10 [%]) second-generation drug-el